{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:37:51Z","timestamp":1790797071007,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11102-022-01242-y","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T09:02:58Z","timestamp":1657098178000},"page":"658-666","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists"],"prefix":"10.1007","volume":"25","author":[{"given":"Khaled M","family":"Al Dahmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mussa H.","family":"Almalki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishah","family":"Ekhzaimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaaeldin","family":"Bashier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeber M.","family":"Mahzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salem A.","family":"Beshyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"1242_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","volume":"72","author":"A Fernandez","year":"2010","unstructured":"Fernandez A, Karavitaki N, Wass JA (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol 72:377\u2013382","journal-title":"Clin Endocrinol"},{"issue":"2","key":"1242_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1017\/cjn.2015.301","volume":"43","author":"K Al-Dahmani","year":"2016","unstructured":"Al-Dahmani K, Mohammad S, Imran F, Theriault C, Doucette S, Zwicker D et al (2016) Sellar Masses: An Epidemiological Study. Can J Neurol Sci 43(2):291\u2013297","journal-title":"Can J Neurol Sci"},{"key":"1242_CR3","doi-asserted-by":"publisher","unstructured":"Delgrange E, Trouillas J, Master D, Donckier J, Tourniaire J (1997) Jul;82(7):2102-7 Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J Clin Endocrinol Metab. DOI: https:\/\/doi.org\/10.1210\/jcem.82.7.4088. PMID: 9215279","DOI":"10.1210\/jcem.82.7.4088"},{"key":"1242_CR4","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1210\/jc.2003-030979","volume":"89","author":"A Colao","year":"2004","unstructured":"Colao A, Vitale G, Cappabianca P, Briganti F, Ciccarelli A, De Rosa M, Zarrili S, Lombardi G (2004) Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. J Clin Endocrinol Metab 89:1704\u20131711","journal-title":"J Clin Endocrinol Metab"},{"key":"1242_CR5","unstructured":"Sibal L, Ugwu P, Kendall-Taylor P, Ball SG, James RA, Pearce SH, Hall K, Quinton R (2002) Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. The proportion of cases exhibiting recovery of pituitary function.Pituitary5243\u2013246"},{"key":"1242_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/cen.12124","volume":"79","author":"N Karavitaki","year":"2013","unstructured":"Karavitaki N, Dobrescu R, Byrne JV, Grossman AB, Wass JAH (2013) Does hypopituitarism recover when macroprolactinomas are treated with cabergoline? Clin Endocrinol 79:217\u2013223","journal-title":"Clin Endocrinol"},{"key":"1242_CR7","doi-asserted-by":"publisher","unstructured":"Barber TM, Kyrou I, Kaltsas G, Grossman AB, Randeva HS, Weickert MO Mechanisms of Central Hypogonadism. Int J Mol Sci. 2021 Jul 30;22(15):8217. DOI: https:\/\/doi.org\/10.3390\/ijms22158217. PMID: 34360982; PMCID: PMC8348115","DOI":"10.3390\/ijms22158217"},{"key":"1242_CR8","doi-asserted-by":"publisher","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA, Endocrine Society (2011) Feb;96(2):273 \u2013 88 ;. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. DOI: https:\/\/doi.org\/10.1210\/jc.2010-1692. PMID: 21296991","DOI":"10.1210\/jc.2010-1692"},{"key":"1242_CR9","first-page":"3053","volume":"85","author":"JJ Pinzone","year":"2000","unstructured":"Pinzone JJ, Katznelson L, Danila DC, Pauler DK, Miller CS, Klibanski A (2000) Primary medical therapy of micro-and macroprolactinomas in men. J Clin Endocrinol Metab 85:3053\u20133057","journal-title":"J Clin Endocrinol Metab"},{"key":"1242_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1210\/jcem-64-2-391","volume":"64","author":"JC Prior","year":"1987","unstructured":"Prior JC, Cox TA, Fairholm D, Kostashuk E, Nugent R (1987) Testosterone-related exacerbation of a prolactin-producing macro- adenoma: possible role for estrogen. J Clin Endocrinol Metab 64:391\u2013394","journal-title":"J Clin Endocrinol Metab"},{"key":"1242_CR11","doi-asserted-by":"crossref","unstructured":"Jayasena CN, Anderson RA, Llahana S, Barth JH, MacKenzie F, Wilkes S, Smith N, Sooriakumaran P, Minhas S, Wu FCW, Tomlinson J, Quinton R (2022 Feb) Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism. Clin Endocrinol (Oxf) 96(2):200\u2013219","DOI":"10.1111\/cen.14633"},{"key":"1242_CR12","doi-asserted-by":"publisher","unstructured":"Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH (2016 Nov) Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101(11):3888\u20133921. DOI: https:\/\/doi.org\/10.1210\/jc.2016-2118. Epub 2016 Oct 13. PMID: 27736313","DOI":"10.1210\/jc.2016-2118."},{"key":"1242_CR13","doi-asserted-by":"publisher","unstructured":"Sehembly M, Lila AR, Sarathi V, Shah R, Sankhe S, Jaiswal SK, Ramteke-Jadhav S, Patil V, Shah N, Bandgar T Predictors of Chronic LH-Testosterone Axis Suppression in Male Macroprolactinomas With Normoprolactinemia on Cabergoline. J Clin Endocrinol Metab. 2020 Dec 1;105(12):dgaa650. DOI: https:\/\/doi.org\/10.1210\/clinem\/dgaa650. PMID: 32942295","DOI":"10.1210\/clinem\/dgaa650"},{"key":"1242_CR14","doi-asserted-by":"crossref","unstructured":"Tirosh, Benbassat C, Lifshitz A, Shimon I (2015) Hypopituitarism patterns and prevalence among men with macroprolactinomas. Pituitary 18:108\u2013115","DOI":"10.1007\/s11102-014-0563-z"},{"key":"1242_CR15","doi-asserted-by":"publisher","unstructured":"Almistehi WM, Vaninetti N, Mustafa S, Hebb ALO, Zwicker D, Doucette S, Alqahtani S, Clarke DB, Imran SA (2020) Dec;23(6):622\u2013629 Secondary pituitary hormonal dysfunction patterns: tumor size and subtype matter. Pituitary. DOI: https:\/\/doi.org\/10.1007\/s11102-020-01067-7. PMID: 32715387","DOI":"10.1007\/s11102-020-01067-7"},{"key":"1242_CR16","doi-asserted-by":"publisher","unstructured":"Smith TP, Suliman AM, Fahie-Wilson MN, McKenna TJ (2002) Dec;87(12):5410-5 Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab. DOI: https:\/\/doi.org\/10.1210\/jc.2001-011943. PMID: 12466327","DOI":"10.1210\/jc.2001-011943"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01242-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-022-01242-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01242-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T10:22:31Z","timestamp":1659435751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-022-01242-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1242"],"URL":"https:\/\/doi.org\/10.1007\/s11102-022-01242-y","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"assertion":[{"value":"19 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors declared any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Research ethics committees of all participating centers approved the study. Cases were identified using ICD 9 and 10 codes (253.2, D35.2, respectively. The condition of consent was waived due to the study\u2019s retrospective nature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical principles"}}]}}